DRTS
Alpha Tau Medical Ltd. Ordinary Shares (DRTS)
$
03About Alpha Tau Medical Ltd. Ordinary Shares (DRTS)
Alpha Tau Medical Ltd. is a clinical-stage oncology therapeutics company, which focuses on the research, development, and commercialization of diffusing alpha-emitters radiation therapy for the treatment of cancer. The firm is involved in the clinical trials at cancer centers with indications that include skin cancer, oral cavity cancer, breast cancer, and pancreatic cancer. The company was founded by Uzi Sofer, Yona Keisari, and Itzhak Kelson in November 2015 and is headquartered in Jerusalem, Israel.
Details
Daily high
$4.12
Daily low
$3.82
Price at open
$4.08
52 Week High
$4.12
52 Week Low
$1.75
Market cap
281.8M
Dividend yield
0.00%
Volume
133,865
Avg. volume
124,952
P/E ratio
-9.49
Alpha Tau Medical Ltd. Ordinary Shares News
Details
Daily high
$4.12
Daily low
$3.82
Price at open
$4.08
52 Week High
$4.12
52 Week Low
$1.75
Market cap
281.8M
Dividend yield
0.00%
Volume
133,865
Avg. volume
124,952
P/E ratio
-9.49